Latest Articles

Publication Date
All News Scientific
Microfibril-associated protein 2 interacts with LEF1/TCF7 and immune infiltration in uterine corpus endometrial carcinoma - Termedia

Microfibril-associated protein 2 interacts with LEF1/TCF7 and immune infiltration in uterine corpus endometrial carcinoma Termedia

Published: Sept. 15, 2025, 1:33 p.m.
Read Full Article
A Lipid Metabolism and Lysosome-based Risk Signature for Prognosis and Immune Response Prediction in Uterine Corpus Endometrial Carcinoma - Frontiers

A Lipid Metabolism and Lysosome-based Risk Signature for Prognosis and Immune Response Prediction in Uterine Corpus Endometrial Carcinoma Frontiers

Published: Aug. 18, 2025, 5:24 p.m.
Read Full Article
CCDC138 Overexpression Predicts Poor Prognosis and Highlights Ciliopathy-Linked Mechanisms in Uterine Corpus Endometrial Carcinoma - Frontiers

CCDC138 Overexpression Predicts Poor Prognosis and Highlights Ciliopathy-Linked Mechanisms in Uterine Corpus Endometrial Carcinoma Frontiers

Published: July 29, 2025, 9:59 a.m.
Read Full Article
Immunogenic Cell Death-Related Genes as Prognostic Biomarkers and Therapeutic Insights in Uterine Corpus Endometrial Carcinoma: An Integrative Bioinformatics Analysis - Frontiers

Immunogenic Cell Death-Related Genes as Prognostic Biomarkers and Therapeutic Insights in Uterine Corpus Endometrial Carcinoma: An Integrative Bioinformatics Analysis Frontiers

Published: July 14, 2025, 4:41 p.m.
Read Full Article
Cyclin D2 --a potential biomarker in uterine corpus endometrial carcinoma through methylation chip and bioinformatic analysis - Frontiers

Cyclin D2 --a potential biomarker in uterine corpus endometrial carcinoma through methylation chip and bioinformatic analysis Frontiers

Published: June 19, 2025, 10:09 p.m.
Read Full Article
Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinoma - Frontiers

Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinoma Frontiers

Published: May 12, 2025, 7:50 p.m.
Read Full Article
MYB Proto-Oncogene Like 2 Identified as a Biomarker for Uterine Corpus Endometrial Carcinoma: evidence from Bioinformatics and Clinical Validation - Frontiers

MYB Proto-Oncogene Like 2 Identified as a Biomarker for Uterine Corpus Endometrial Carcinoma: evidence from Bioinformatics and Clinical Validation Frontiers

Published: April 23, 2025, 2:47 p.m.
Read Full Article
Engineered Exosomes Restore miR-508-5p Expression in Uterine Corpus Endometrial Carcinoma and Reduce Tumor Progression and Metastasis by Targeting DLL3 - Frontiers

Engineered Exosomes Restore miR-508-5p Expression in Uterine Corpus Endometrial Carcinoma and Reduce Tumor Progression and Metastasis by Targeting DLL3 Frontiers

Published: Feb. 3, 2025, 2:27 p.m.
Read Full Article
Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma - Nature.com

Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma Nature.com

Published: Jan. 17, 2025, 8:46 a.m.
Read Full Article
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma - Nature.com

A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma Nature.com

Published: Jan. 9, 2025, 7:28 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!